Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemotherapy, Concurrent”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT07127315
What this trial is testing

Gonadotropin-Releasing Hormone Agonists Benefit in Preserving the Ovarian Function in Premenopausal Breast Cancer Patients During Chemotherapy

Who this might be right for
Gonadotropin Releasing Hormone AgonistsOvarian FunctionPremenopausal+2 more
Helwan University 100
Testing effectiveness (Phase 2)UnknownNCT01232374
What this trial is testing

Nimotuzumab in Combination With Chemoradiation for Local Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma
Biotech Pharmaceutical Co., Ltd. 144
Large-scale testing (Phase 3)UnknownNCT01579591
What this trial is testing

VSL#3 Versus Placebo in Increasing the Pathological Major Response Rate in Patients With Rectal Cancer

Who this might be right for
Rectal Cancer
Catholic University of the Sacred Heart 160
Testing effectiveness (Phase 2)Study completedNCT03371550
What this trial is testing

A Phase II Trial of Cisplatin-Docetaxel Induction Plus Concurrent 3-D Conformal Radiotherapy and Weekly Chemotherapy

Who this might be right for
Locally Advanced Non-small Cell Lung Cancer
Centre Antoine Lacassagne 44
Testing effectiveness (Phase 2)Looking for participantsNCT06177925
What this trial is testing

A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC

Who this might be right for
Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by Site+7 more
Nanfang Hospital, Southern Medical University 62
Testing effectiveness (Phase 2)UnknownNCT01594099
What this trial is testing

Concurrent Chemoradiotherapy for Cervical Cancer in Elderly Women

Who this might be right for
Cervical Cancer
Xi'an Jiaotong University 45
Not applicableUnknownNCT05262452
What this trial is testing

Concurrent FOLFIRINOX Plus High Intensity Focused Ultrasound for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Non-resectableChemotherapy EffectUltrasound Therapy
Seoul National University Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00003089
What this trial is testing

Chemotherapy, Amifostine, and Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLung Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Not applicableStudy completedNCT00907140
What this trial is testing

Fludeoxyglucose (FDG) Positron Emission Tomography/Computed Tomography (PET/CT) Cervical Heterogenity Imaging Study

Who this might be right for
Cervical Cancer
Washington University School of Medicine 25
Testing effectiveness (Phase 2)UnknownNCT04828395
What this trial is testing

Fluzoparib Combined With Camrelizumab for Maintenance Treatment of Locally Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 65
Large-scale testing (Phase 3)Looking for participantsNCT05735145
What this trial is testing

Concurrent Chemoradiotherapy Combined With Adjuvant Chemotherapy Treated Advanced Cervical Cancer

Who this might be right for
Uterine Cervical NeoplasmsChemoradiotherapyAdjuvant Chemotherapy
Fourth Affiliated Hospital of Guangxi Medical University 108
Testing effectiveness (Phase 2)UnknownNCT01340508
What this trial is testing

Preoperative Concurrent Chemotherapy and Intensity Modulated Radiotherapy (IMRT) in Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancers.
National University Hospital, Singapore 63
Testing effectiveness (Phase 2)UnknownNCT00817583
What this trial is testing

Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma (NPC)

Who this might be right for
Nasopharyngeal Carcinoma
Fudan University 100
Testing effectiveness (Phase 2)Study completedNCT00601705
What this trial is testing

Epirubicin, Oxaliplatin and Fluorouracil (EOF) in Cancer of the Esophagus, Gastroesophageal Junction, or Stomach

Who this might be right for
Esophageal CancerGastric Cancer
Case Comprehensive Cancer Center 61
Large-scale testing (Phase 3)Active Not RecruitingNCT05979961
What this trial is testing

Phase III Trial of Concurrent Chemotherapy Alone in Patients With Low-risk Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 464
Not applicableLooking for participantsNCT04409860
What this trial is testing

The Efficacy of Adjuvant Chemotherapy in Locally Advanced Cervical Cancer

Who this might be right for
Cervical Cancer
Chongqing University Cancer Hospital 120
Early research (Phase 1)Study completedNCT00707278
What this trial is testing

Radiation Therapy and Capecitabine/Oxaliplatin Chemotherapy in the Treatment of Locally Advanced Pancreas Adenocarcinoma

Who this might be right for
CancerPancreas
University of Utah 13
Large-scale testing (Phase 3)Study completedNCT00326378
What this trial is testing

Efficacy Study of Additional Chemotherapy After Concurrent Chemoradiation in Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Samsung Medical Center 434
Not applicableStudy completedNCT00908609
What this trial is testing

Optical Tomography With Ultrasound Guidance

Who this might be right for
Breast Cancer
UConn Health 340
Not applicableWithdrawnNCT05488626
What this trial is testing

Daily Adaptive Radiation Therapy: An Individualized Approach for Stage III Lung Cancer

Who this might be right for
Stage III Non-small Cell Lung Cancer
Varian, a Siemens Healthineers Company
Next Page